Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.

Clinical pharmacology and therapeutics - 1 Jun 2006

Toornvliet Rolf, van Berckel Bart N M, Luurtsema Gert, Lubberink Mark, Geldof Albert A, Bosch Tessa M, Oerlemans Ruud, Lammertsma Adriaan A, Franssen Eric J F

Abstract excerpt

INTRODUCTION: P-glycoprotein (P-gp) is an efflux transporter responsible for the transport of various drugs across the blood-brain barrier (BBB). Loss of P-gp function with age may be one factor in the development and progression of neurodegenerative diseases. The aim of this study was to assess...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Area Under Curve
Share to ATP Binding Cassette Transporter, Subfamily B, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Blood-Brain Barrier

Share to Carbon Radioisotopes

Share to Injections, Intravenous

Share to Pilot Projects

Share to Positron-Emission Tomography

Share to Verapamil

Source

Identifiers

PMID: 16765142
DOI: 10.1016/j.clpt.2006.02.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-16765142-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of age on functional P-glycoprotein in the blood-brain barrier measured by use of (R)-[(11)C]verapamil and positron emission tomography.PMID 16765142Read ↗

Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: a PET study with [(11)C]verapamil as a probe for P-glycoprotein function.Semantic proximity Read ↗

Blood–brain barrier P-glycoprotein function in healthy subjects and Alzheimer's disease patients: effect of polymorphisms in the ABCB1 geneSemantic proximity Read ↗

Evaluation of in vivo P-glycoprotein function at the blood-brain barrier among MDR1 gene polymorphisms by using 11C-verapamil.Semantic proximity Read ↗

Blood-Brain Barrier P-Glycoprotein Function in Neurodegenerative DiseaseSemantic proximity Read ↗

The role of the efflux transporter, P‐glycoprotein, at the blood–brain barrier in drug discoverySemantic proximity Read ↗

Impaired Clearance From the Brain Increases the Brain Exposure to Metoclopramide in Elderly Subjects.Semantic proximity Read ↗

Radiopharmaceuticals for assessing ABC transporters at the blood–brain barrierSemantic proximity Read ↗

Parametric imaging of P-glycoprotein function at the blood-brain barrier using kE,brain-maps generated from [11C]metoclopramide PET data in rats, nonhuman primates and humansSemantic proximity Read ↗

Age-related changes in P-glycoprotein expression in senescence-accelerated mouse.Semantic proximity Read ↗

Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans.Semantic proximity Read ↗

Influence of functional haplotypes in the drug transporter gene on central nervous system drug distribution in humansSemantic proximity Read ↗

Functional Expression and Localization of P-glycoprotein in the Central Nervous System: Relevance to the Pathogenesis and Treatment of Neurological DisordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.